Registration opens for the 11th Adaptive Designs in Clinical Trials

SMi’s Adaptive Designs in Clinical Trials to return in London next Spring

SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019. With the growing popularity in use and acceptance of adaptive designs in clinical trials - demonstrated most recently with the new FDA draft guidance on adaptive designs – there is a pressing need for a forum which explores this increasingly normalized medical methodology.

Hosting in depth presentations from regulatory agencies, researchers and biostatisticians, the meeting will cover how personalized medicine, platform trials, response-adaptive randomization, signature designs, estimand framework, bayesian methods and digital innovation are revolutionizing the drug development process both in Europe and North America.

Featured speakers include:

Sandeep Menon, Vice President and Head of Early Clinical Development, Pfizer
Simon Wandel, Associate Director, Statistical Methodology and Consulting, Novartis
Solange Corriol-Rohou, Senior Director Regulatory Affairs and Policy, EU, AstraZeneca
Christine Fletcher, Executive Director Biostatistics, Amgen
Philip Hougaard, Vice President Biometrics, Lundbeck
Beatrice Panico, Medical Assessor, MHRA
Kaspar Rufibach, Principal Statistical Scientist, Roche
Andrea Callegaro, Senior Manager, Biostatistician, GSK Vaccines
Sofia Villar, Senior Statistician, MRC Centre

A few event highlights include:

See how the regulatory environment for adaptive drug design is shifting across the continent with insights from the MHRA, Amgen, AstraZeneca and Berry Consulting
Explore the therapeutic potential of adaptive designs with real-world examples from H.Lundbeck, GSK Vaccines, Pfizer and Novartis
Listen to how the latest platform trial case studies, such as that of the EPAD project and the MS Society initiative, are impacting pharmaceutical development
Delve into the long-standing discussion of Bayesian vs. frequentist designs
Discover the latest research in response-adaptive designs: trials for rare diseases and looking forward

A complete list of speakers and their presentations is available to view at www.adaptivedesigns.co.uk/Pharmapr1

Registration is live on the website. A £400 Early Bird discount is currently available for bookings made by 14^th December.

Who should attend:

Biostatisticians
Clinical project managers
Clinical research advisors
Clinical Trials Directors
Clinical scientists
Statisticians
Quantitative scientists

ADAPTIVE DESIGNS IN CLINICAL TRIALS
1-2 April 2019
Holiday Inn Kensington Forum, London, UK
www.adaptivedesigns.co.uk/Pharmapr1

--- ENDS ---

Contact Information:

For media enquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: hsidhu@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk